GL1X · GenesisL1 explorer

MolNFT v1 · #29994 · protein

Factor XI catalytic domain complexed with N-((R)-1-(4-bromophenyl) ETHYL)UREA-asn-val-arg-alpha-ketothiazole

1ZPZ · Coagulation factor XI: “Factor XI catalytic domain complexed with N-((R)-1-(4-bromophenyl) ETHYL)UREA-asn-val-arg-alpha-ketothiazole”. X-ray diffraction, 2 ligands (BUK, SO4), 2 pockets (best druggability 0.46). MolNFT v1 #29994 on…

PDB
1ZPZ
Type
protein
Length
233 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Coagulation factor XI
EC
3.4.21.27
UniProt
P03951
Ligands
BUK, SO4
Pockets
2 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACoagulation factor XI (EC 3.4.21.27)protein23315% helix, 35% strandP03951

Ligands and binding sites

  • BUK · N~2~-({[(1R)-1-(4-bromophenyl)ethyl]amino}carbonyl)asparaginyl-N~1~-{4-{[amino(imino)methyl]amino}-1-[2,3-dihydro-1,3-thiazol-2-yl(hydroxy)methyl]butyl}valinamide · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11130.460.7933BUK
21090.390.7523empty

Modifications

Observed in the structure: 4 disulfide, 1 covalent (disulfide, covalent ligand).

Compared structures

  • 1ZPZ · Factor XI catalytic domain complexed with N-((R)-1-(4-bromophenyl)ethyl)urea-Asn-Val-Arg-a… · the same entry in another collection · chain A against A, TM-score 1.00
  • P03951 · AlphaFold monomer V2.0 prediction for coagulation factor XI (P03951) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.